Digital Frontiers Health at 10: Future health, cost, and collaborati... Frontiers Health is all about global innovation, the future of health unfolding by grace of science across the world.
Digital AI doesn’t have to be 100% reliable to be useful Generative AI models aren’t perfect. They hallucinate and make mistakes. But that doesn't have to be disqualifying, say AI implementation experts.
Digital From fragmented to focused: Transforming field engagement wi... The promise of agentic AI extends beyond operational efficiency, freeing field teams from administrative burdens and empowering them.
Digital Changing Faces – Digital and supplier hires – August and Sep... There was plenty of personnel action in August and September among pharmaceutical suppliers, particularly in the clinical trial technology sector.
Digital Towards one, cohesive AI workflow: In conversation with Ilya... In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Ilya Burkov, global head of healthcare & life sciences at Nebius, about AI.
Digital AI could save the NHS, but risks sharing private patient dat... It’s becoming increasingly evident that simply anonymising and de-identifying sensitive data is no panacea for big tech’s data privacy problem.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
